Journal
International Journal of Rheumatic Diseases
Volume 17, Issue 8, Pages 872-877Publisher
WILEY-BLACKWELL
DOI: 10.1111/1756-185X.12443
Keywords
IgA rheumatoid factor; rheumatoid arthritis; rheumatoid factor isotypes; tumour necrosis factor inhibitors
Categories
Funding
- APLAR Research Grant Award
Ask authors/readers for more resources
AimThe main objective of this study is to elucidate the role of immunoglobulin A (IgA) rheumatoid factor (RF) in predicting the clinical response to tumour necrosis factor inhibitors (TNFi) among patients with rheumatoid arthritis (RA). MethodWe recruited all patients with RA who were ever on TNFi for a minimum duration of 3months at our centre. Based on the European League Against Rheumatism response criteria, subjects were further divided into responders and non-responders. Age-matched RA patients who were on conventional disease-modifying anti-rheumatic drugs and in remission were enrolled as controls. Subjects were tested for quantitative values of IgA, IgM, IgG RF and anti-citrulinated cyclic peptides (CCP). Further, all subjects were assessed for the disease activity score that includes 28 joints (DAS28) and Stanford Health Assessment Questionnaire (HAQ) 8-item Disability Index (HAQ-DI). ResultsA total of 31 subjects with RA who had received TNFi and 15 controls were enrolled in this study. There was a trend for the non-responders (n=10) to have higher levels of all isotypes of RF and anti-CCP. However, only the IgA RF and anti-CCP levels were significantly higher in the non-responder group compared to the responders and controls (P=0.001, P=0.034, respectively). On multivariate analysis, only the IgA RF remained significant (OR 0.989; 95% CI 0.980-0.999; P=0.026). ConclusionIgA RF is potentially a novel predictor of response to TNFi in RA patients. Testing for pretreatment IgA RF levels could be a reasonable consideration before commencement of TNFi.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available